Published in J Clin Virol on December 01, 2005
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
Hepatocyte death: a clear and present danger. Physiol Rev (2010) 2.18
Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut (2008) 1.86
Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol (2009) 1.56
Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J Hepatol (2012) 1.45
The increasing burden of imported chronic hepatitis B--United States, 1974-2008. PLoS One (2011) 1.37
Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy. World J Gastroenterol (2014) 1.36
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One (2007) 1.34
A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol (2011) 1.17
Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS One (2011) 1.11
European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypes. J Clin Microbiol (2006) 1.08
Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol (2014) 1.08
Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol (2014) 1.05
Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus. J Clin Microbiol (2008) 1.00
Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches. Saudi J Gastroenterol (2012) 0.99
Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J Gastroenterol (2014) 0.98
Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China. PLoS One (2013) 0.98
Health state utilities and quality of life in patients with hepatitis B. Can J Gastroenterol (2012) 0.97
A population based study on hepatitis B virus in northern iran, amol. Hepat Mon (2014) 0.97
Male-specific W4P/R mutation in the pre-S1 region of hepatitis B virus, increasing the risk of progression of liver diseases in chronic patients. J Clin Microbiol (2013) 0.97
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol (2006) 0.97
Clinical features of acute viral hepatitis B in Korea: a multi-center study. Korean J Hepatol (2011) 0.97
Low immune response to hepatitis B vaccine among children in Dakar, Senegal. PLoS One (2012) 0.95
Hepatitis B virus infection in Latin America: a genomic medicine approach. World J Gastroenterol (2014) 0.94
Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections. J Infect Dis (2010) 0.93
Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. World J Gastroenterol (2009) 0.92
Commentary: eight ways to prevent cancer: a framework for effective prevention messages for the public. Cancer Causes Control (2012) 0.92
Hepatitis B virus burden in developing countries. World J Gastroenterol (2015) 0.91
Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virol J (2013) 0.89
Role of IL-4 gene polymorphisms in HBV-related hepatocellular carcinoma in a Chinese population. PLoS One (2014) 0.89
Innate antiviral immune responses to hepatitis B virus. Viruses (2010) 0.88
Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B. Ann Lab Med (2013) 0.88
The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology. PLoS One (2014) 0.88
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy. BMC Infect Dis (2015) 0.87
Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity. World J Gastroenterol (2015) 0.87
High burden of hepatitis B infection in Northern Uganda: results of a population-based survey. BMC Public Health (2013) 0.86
Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World J Hepatol (2014) 0.85
Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010. J Clin Virol (2013) 0.85
Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection. PLoS One (2014) 0.84
Simultaneous genotyping and quantification of hepatitis B virus for genotypes B and C by real-time PCR assay. J Clin Microbiol (2010) 0.84
Hepatitis B Virus Infection, MicroRNAs and Liver Disease. Int J Mol Sci (2015) 0.83
Prevalence, sociodemographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria. Pan Afr Med J (2015) 0.82
Clinical significance of hepatitis B surface antigen mutants. World J Hepatol (2015) 0.82
Peroxisome proliferator-activated receptors in HBV-related infection. PPAR Res (2009) 0.82
Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation. Sci Rep (2015) 0.82
Role of Marine Natural Products in the Genesis of Antiviral Agents. Chem Rev (2015) 0.82
Prevalence and risk factors of hepatitis B virus infection in Bahrain, 2000 through 2010. PLoS One (2014) 0.82
Hepatitis B Virus Core Protein Phosphorylation Sites Affect Capsid Stability and Transient Exposure of the C-terminal Domain. J Biol Chem (2015) 0.82
The hepatitis B virus ribonuclease H as a drug target. Antiviral Res (2015) 0.81
HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study. BMC Infect Dis (2015) 0.81
Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients. ISRN Gastroenterol (2011) 0.81
MicroRNAs may solve the mystery of chronic hepatitis B virus infection. World J Gastroenterol (2013) 0.80
Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis. Evid Based Complement Alternat Med (2012) 0.80
Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy. Hepatol Int (2010) 0.80
Glucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells. J Biol Chem (2014) 0.80
Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids. Clin Vaccine Immunol (2011) 0.79
Mutation profiling of the hepatitis B virus strains circulating in North Indian population. PLoS One (2014) 0.79
Management of hepatocellular carcinoma rupture in the caudate lobe. World J Gastroenterol (2015) 0.79
Medical training fails to prepare providers to care for patients with chronic hepatitis B infection. World J Gastroenterol (2015) 0.79
Discovery of a Novel Mutation (X8Del) Resulting in an 8-bp Deletion in the Hepatitis B Virus X Gene Associated with Occult Infection in Korean Vaccinated Individuals. PLoS One (2015) 0.79
A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes. Protein Cell (2014) 0.79
Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses. Int J Clin Exp Med (2014) 0.78
Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe. Infect Agent Cancer (2009) 0.78
Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009. BMC Infect Dis (2011) 0.78
Post-partum reactivation of chronic hepatitis B virus infection among hepatitis B e-antigen-negative women. World J Gastroenterol (2015) 0.78
Functional Characterization of Interferon Regulation Element of Hepatitis B virus Genome In Vivo. Indian J Virol (2012) 0.78
Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus. Appl Environ Microbiol (2014) 0.78
Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen. Sci Rep (2016) 0.78
A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity. PLoS One (2015) 0.78
Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination. Hum Vaccin Immunother (2014) 0.78
Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma: a comparative analysis. Int J Clin Oncol (2011) 0.77
Health literacy in patients with chronic hepatitis B attending a tertiary hospital in Melbourne: a questionnaire based survey. BMC Infect Dis (2014) 0.77
Relationship between platelet parameters and hepatic pathology in patients with chronic hepatitis B infection - a retrospective cohort study of 677 patients. J Int Med Res (2016) 0.77
Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes. Hepat Med (2010) 0.77
Hepatitis B virus preS1 deletion is related to viral replication increase and disease progression. World J Gastroenterol (2015) 0.77
The Seroprevalence of Hepatitis B in Akbar Abad Village, Kavar, Southern Iran. Int J Prev Med (2014) 0.77
YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy. Hepat Mon (2015) 0.77
Development of Fok-I based nested polymerase chain reaction-restriction fragment length polymorphism analysis for detection of hepatitis B virus X region V5M mutation. World J Gastroenterol (2015) 0.76
Guidelines for the detection of a common source of hepatitis B virus infections. Hepat Mon (2011) 0.76
Mannose-binding lectin and ficolin-2 do not influence humoral immune response to hepatitis B vaccine. Vaccine (2014) 0.76
Hepatitis B virus genotypes among chronic hepatitis B patients reporting at Korle-Bu teaching hospital, Accra, Ghana. Pan Afr Med J (2016) 0.75
Caregiver burden and its determinants among family members of patients with chronic viral hepatitis in Shanghai, China: a community-based survey. BMC Infect Dis (2014) 0.75
Importance of endocytic pathways in liver function and disease. Compr Physiol (2014) 0.75
Immune Responses to Single-Dose Versus Double-Dose Hepatitis B Vaccines in Healthcare Workers not Responding to the Primary Vaccine Series: A Randomized Clinical Trial. Hepat Mon (2016) 0.75
The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway. PLoS One (2011) 0.75
Update on entecavir in the management of severe forms of Hepatitis B. Hepat Med (2012) 0.75
Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis. Gut Liver (2015) 0.75
Potential of Cannabidiol for the Treatment of Viral Hepatitis. Pharmacognosy Res (2017) 0.75
Alanine aminotransferase is an inadequate surrogate marker for detecting lamivudine resistance. World J Gastroenterol (2010) 0.75
Recent epidemiological and clinical features of acute hepatitis B in a single center of China. Int J Clin Exp Med (2015) 0.75
Comprehensive review of telbivudine in pregnant women with chronic hepatitis B. World J Hepatol (2016) 0.75
Immunotherapy against cancer-related viruses. Cell Res (2016) 0.75
Serum IL-21 levels associated with chronic hepatitis B and hepatitis B-related liver failure. Exp Ther Med (2014) 0.75
Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B Infection. Hepat Mon (2016) 0.75
Prevention and treatment of hepatitis virus infections in hematopoietic stem cell transplant recipients. Mediterr J Hematol Infect Dis (2009) 0.75
Comparative Transcriptomic Analysis of Primary Duck Hepatocytes Provides Insight into Differential Susceptibility to DHBV Infection. PLoS One (2016) 0.75
A major shift of viral and nutritional risk factors affects the hepatocellular carcinoma risk among Ivorian patients: a preliminary report. Infect Agent Cancer (2015) 0.75
An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice. Exp Anim (2016) 0.75
Presence of anti-HBs antibodies in blood donors 18-22 years after vaccination and implications for the selection of candidates for plasmapheresis for the production of hyperimmune plasma. Blood Transfus (2015) 0.75
Identification of Novel A2/C2 Inter-Genotype Recombinants of Hepatitis B Virus from a Korean Chronic Patient Co-Infected with Both Genotype A2 and C2. Int J Mol Sci (2017) 0.75